Abstract
The gross appearance does not distinguish developing and established fibrotic lesions induced by bleomycin from injury caused by drugs or other chemicals. After a single intravenous dose fibrosis is multifocal, rarely confluent; diffuse lobular and lobar fibrosis follow endotracheal administration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson IYR, Bowden DH (1974) The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol77:185198
Adamson IYR, Bowden DH (1977) Origin of ciliated alveolar epithelial cells in bleomycin-induced lung injury. Am J Pathol 87:569–580
Adamson IYR, Bowden DH (1979) Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung. Am J Pathol 96:531–544
Adamson IYR, King G (1985) Epithelial-mesenchymal inter-actions in postnatal rat lung growth. Exp Lung Res 8: 261–274
Adamson IYR, Young L, Bowden DH (1988) Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130:377–383
Adamson IYR, Hedgecock C, Bowden DH (1990) Epithelial cell-fibroblast interactions in lung injury and repair. Am J Pathol 137:385–392
Bedrossian CWM, Greenberg SD, Yawn DH, O’Neal RM (1977) Experimentally induced bleomycin sulfate pulmonary toxicity. Histopathologic and ultrastructural study in the pheasant. Arch Pathol Lab Med 101:248–254
Bowden DH, Hedgecock C, Adamson IYR (1989) Silica-in-duced pulmonary fibrosis involves the reaction of particles with interstitial rather than alveolar macrophages. J Pathol 158:73–80
Breen E, Shull S, Burne S, Absher M, Kelley J, Phan S, Cutroneo KR (1992) Bleomycin regulation of transforming growth factor-ß mRNA in rat lung fibroblasts. Am J Respir Cell Mol Biol 6:146–152
Brownstein DG (1985) Sendai virus infection, lung, mouse and rat. In: JonesTC,MohrU,HuntRD (eds) Monographs on pathology of laboratory animals: respiratory system. Springer, Berlin Heidelberg New York, pp 194–203
Burger RM, Peisach J, Horwitz SB (1981) Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem 256: 11636 - 11644
Chauncey JB, Peters-Golden M, Simon RH (1988) Arachidonic acid metabolism by rat alveolar epithelial cells. Lab Invest 58:133–140
Denholm EM, Rollins SM (1993) Expression and secretion of transforming growth factor-ß by bleomycin-stimulated rat alveolar macrophages. Am J Physiol 264 (Lung Cell Mol Physiol 8): L36 - L42
Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJP, Angel P, Heath JK (1987) Transforming growth factor ß modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6: 1899 - 1904
Elson N, Szapiel S, Fulmer J, Crystal R (1977) Role of cell-mediated immunity in bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 115 [Suppl]: 54 (abstract)
Fleischman RW, Baker JR, Thompson GR, Schaeppi UH, Ilievesky VR, Cooney DA, Davis RD (1971) Bleomycin-induced interstitial pneumonia. Thorax 26:675–682
Giri SN (1986) Pharmacokinetics, subcellular distribution and co-valent binding of [3H] bleomycin in hamsters after endotracheal administration. Exp Mol Pathol 45:207–220
Goldstein R, Polgar P (1982) The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 257:8630–8633
Hay JG, Haslam PL, Dewar A, Addis B, Turner-Warwick M, LaurentGJ (1987) Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. Thorax 42:374– 382
Howe PH, Draetta G, Leof EB (1990) Transforming growth factor ßl inhibition of p34cdc2 phosphorylation and histone HI kinase activity is associated with Gl/S-phase growth arrest. Mol Cell Biol 11: 1185–1194
Hoyt DG, Lazo JS (1988) Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor ß precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 246:765–771
Klein JH, Adamson IYR (1989) Fibroblast inhibition and prostaglandin secretion by alveolar epithelial cells exposed to silica. Lab Invest 60: 808–813
Laurent G, McAnulty RJ (1983) Protein metabolism during bleomycin-induced pulmonary fibrosis in rabbits. Am Rev Respir Dis 128:82–88
Lazo JS, Pham ET (1984) Pulmonary fate of [3H] bleomycin A2 in mice. J Pharmacol Exp Ther 228:13–18
Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, SakselaO,BlasiF,DanoK (1987)Transforming growth factor-ß is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in Wl-38 human lung fibroblasts. EMBO J 6:1281–1286
Mangum JB, Everitt JI, Bonner JC, Moore LR, Brody AR (1990) Co-culture of primary pulmonary cells to model alveolar injury and translocation of proteins. In Vitro Cell Dev Biol 26:135– 1143
McCullough B, Schneider S, Greene ND, Johanson WG Jr (1978) Bleomycin-induced lung injury in baboons: alterations of cells and immunoglobulins recoverable by bronchoalveolar lavage. Lung 155:337–358
Phan SH, Kunkel SL (1992) Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18:29–43
Phan SH, Thrall RS, Williams C (1981) Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism. Am Rev Respir Dis 124:428–434
Phan SH, Gharaee-Kermani M, Wolber F, Ryan US (1991) Stimulation of rat endothelial cell transforming growth factor-ß production by bleomycin. J Clin Invest 87:148–154
Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P (1989) Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170:655–663
Raghow R, Irish P, Kang AH (1989) Coordinate regulation of transforming growth factor ß gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced fibrosis. J Clin Invest 84: 1836–1842
Schrier DJ, Phan SH (1987) Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide- sensitive T cells. Am J Pathol 116:270–278
Schrier DJ, Phan SH, Ward PA (1982) Cellular sensitivity to collagen in bleomycin-treated rats. J Immunol 129:2156–2159
Schrier DJ, Kunkel RG, Phan SH (1983a) The role of strain variation in murine bleomycin-induced pulmonary fibrosis.Am Rev Respir Dis 127:63–66
Schrier DJ, Phan SH, McGarry BM (1983b) The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127:614–617
Snider GL, Celli BR, Goldstein RH, O’Brien J, Lucey EG (1978) Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Am Rev Respir Dis 117:289–297
Thrall RS, McCormick J, Jack R, Phan SH, Ward PA (1979) The effect of anti-lymphocyte globulin on the development of pulmonary fibrosis in the rat. Am Rev Respir Dis 119 [Suppl]: 83
Umezawa H (1974) Chemistry and mechanism of action of bleomycin. Fed Proc 33:2296–2302
Vilcek J, Palombella VJ, Henrikson-De-Stephano D, Swenson C,FeinmanR,HiraiM,TsujimotoM(1986) Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163:632–643
Wahl SM, McCartney-Francis N, Dougherty EB, Dougherty SF (1990) Macrophage production of TGF-ß and regulation by TGF-ß. Ann NY Acad Sci 593:188–196
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bowden, D.H. (1996). Bleomycin-Induced Injury, Mouse. A Model for Lung Injury. In: Jones, T.C., Dungworth, D.L., Mohr, U. (eds) Respiratory System. Monographs on Pathology of Laboratory Animals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61042-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-61042-4_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64667-6
Online ISBN: 978-3-642-61042-4
eBook Packages: Springer Book Archive